Update in General Internal Medicine: Evidence Published in 2014
Authors: Reena H. Hemrajani, Stephanie A. Call
Journal: Annals of Internal Medicine (2015)

Updates5 May 2015Update in General Internal Medicine: Evidence Published in 2014Reena H. Hemrajani, MD and Stephanie A. Call, MD, MSPHReena H. Hemrajani, MDFrom Virginia Commonwealth University, Richmond, Virginia.Search for more papers by this author and Stephanie A. Call, MD, MSPHFrom Virginia Commonwealth University, Richmond, Virginia.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M15-0274 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Our goal was to select articles published in 2014 that are likely to help clinicians provide high-value care for ambulatory patients. To that end, we identified articles in ACP JournalWise that were “highest rated” or “most read.” We also searched MEDLINE by using 10 search topics rated highly by a panel of practicing generalists.We selected one article out of several that compared novel oral anticoagulants with warfarin in the management of atrial fibrillation. We also chose an article that evaluated the role of prolonged cardiac monitoring to detect atrial fibrillation in patients with cryptogenic stroke. In addition, we selected ...References1. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-51. [PMID: 19717844] doi:10.1056/NEJMoa0905561 CrossrefMedlineGoogle Scholar2. Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation. 2011;123:2363-72. [PMID: 21576658] doi:10.1161/CIRCULATIONAHA.110.004747 CrossrefMedlineGoogle Scholar3. Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O'Donnell MJ, et al; Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13:429-38. [PMID: 24646875] doi:10.1016/S1474-4422(13)70310-7 CrossrefMedlineGoogle Scholar4. Flint AC, Banki NM, Ren X, Rao VA, Go AS. Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry. Stroke. 2012;43:2788-90. [PMID: 22871679] CrossrefMedlineGoogle Scholar5. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857-67. [PMID: 17577005] LinkGoogle Scholar6. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58:113-30. [PMID: 6966542] MedlineGoogle Scholar7. Goldstein LB, Jones MR, Matchar DB, Edwards LJ, Hoff J, Chilukuri V, et al. Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria. Stroke. 2001;32:1091-8. [PMID: 11340215] CrossrefMedlineGoogle Scholar8. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al; European Heart Rhythm Association. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369-429. [PMID: 20802247] doi:10.1093/eurheartj/ehq278 CrossrefMedlineGoogle Scholar9. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al; American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e419S-94S. [PMID: 22315268] doi:10.1378/chest.11-2301 CrossrefMedlineGoogle Scholar10. Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92:199-205. [PMID: 17296569] CrossrefMedlineGoogle Scholar11. Boutitie F, Pinede L, Schulman S, Agnelli G, Raskob G, Julian J, et al. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. BMJ. 2011;342:d3036. [PMID: 21610040] doi:10.1136/bmj.d3036 CrossrefMedlineGoogle Scholar12. Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, et al; PROLONG Investigators (on behalf of Italian Federation of Anticoagulation Clinics). Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. Blood. 2010;115:481-8. [PMID: 19965693] doi:10.1182/blood-2009-08-237354 CrossrefMedlineGoogle Scholar13. Prandoni P, Prins MH, Lensing AW, Ghirarduzzi A, Ageno W, Imberti D, et al; AESOPUS Investigators. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial. Ann Intern Med. 2009;150:577-85. [PMID: 19414836] LinkGoogle Scholar14. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:136-43. [PMID: 18250205] doi:10.1513/pats.200709-155MG CrossrefMedlineGoogle Scholar15. Qaseem A, Snow V, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010;153:194-9. [PMID: 20679562] doi:10.7326/0003-4819-153-3-201008030-00010 LinkGoogle Scholar16. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29. [PMID: 24399786] doi:10.3322/caac.21208 CrossrefMedlineGoogle Scholar17. Pinsky PF, Church TR, Izmirlian G, Kramer BS. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013;119:3976-83. [PMID: 24037918] doi:10.1002/cncr.28326 CrossrefMedlineGoogle Scholar18. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72. [PMID: 12748199] CrossrefMedlineGoogle Scholar19. Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington, DC: National Academies Press; 2011. Google Scholar20. Gonzales R, Anderer T, McCulloch CE, Maselli JH, Bloom FJ, Graf TR, et al. A cluster randomized trial of decision support strategies for reducing antibiotic use in acute bronchitis. JAMA Intern Med. 2013;173:267-73. [PMID: 23319069] doi:10.1001/jamainternmed.2013.1589 CrossrefMedlineGoogle Scholar21. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-20. [PMID: 24352797] doi:10.1001/jama.2013.284427 CrossrefMedlineGoogle Scholar22. Go AS, Bauman MA, ColemanKing SM, Fonarow GC, Lawrence W, Williams KA, et al; American Heart Association. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2014;63:878-85. [PMID: 24243703] doi:10.1161/HYP.0000000000000003 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Virginia Commonwealth University, Richmond, Virginia.Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-0274.Corresponding Author: Stephanie A. Call, MD, MSPH, PO Box 980509, 1200 East Broad Street, Richmond, VA 23298; e-mail, [email protected]edu.Current Author Addresses: Drs. Hemrajani and Call: PO Box 980509, 1200 East Broad Street, Richmond, VA 23298.Author Contributions: Analysis and interpretation of the data: R.H. Hemrajani.Drafting of the article: R.H. Hemrajani, S.A. Call.Critical revision of the article for important intellectual content: R.H. Hemrajani, S.A. Call.Final approval of the article: R.H. Hemrajani, S.A. Call.Administrative, technical, or logistic support: S.A. Call.Collection and assembly of data: R.H. Hemrajani, S.A. Call.This article was published online first at www.annals.org on 30 April 2015. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 5 May 2015Volume 162, Issue 9Page: W80-W85KeywordsAntibioticsAtrial fibrillationBlood pressureHypertensionLung and intrathoracic tumorsSleep apneaStrokeUltrasound imagingVaccines ePublished: 5 May 2015 Issue Published: 5 May 2015 CopyrightCopyright © 2015 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...